Actively Recruiting
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
Led by Incyte Corporation · Updated on 2025-12-11
5621
Participants Needed
1
Research Sites
281 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is to assess infant outcomes of women with AD who were exposed to ruxolitinib cream during pregnancy compared with a control cohort of women with AD who were exposed to a topical corticosteroid (TCS) during pregnancy.
CONDITIONS
Official Title
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women aged 14 years or older at pregnancy outcome
- Pregnancy after FDA approval of ruxolitinib cream for AD on 21 SEP 2021
- At least one pharmacy claim for ruxolitinib cream or a topical corticosteroid
- Diagnosis of atopic dermatitis before or on the day of first pharmacy claim from 6 months before estimated conception
- Continuous enrollment in the database from 6 months before conception through pregnancy end
- Mother-infant data linkage available for infant outcome analysis
- Infants followed up to 1 year after birth with continuous enrollment
You will not qualify if you...
- Pharmacy claims for oral ruxolitinib or other JAK inhibitors during the exposure window for the outcome
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Syneos Health (remote site)
Morrisville, North Carolina, United States, 27560
Actively Recruiting
Research Team
I
Incyte Corporation Call Center (US)
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here